Whole protein or long peptides in therapeutic vaccination strategies, does it make a difference?
Expert Opin Biol Ther
.
2023 Feb;23(2):115-117.
doi: 10.1080/14712598.2022.2156784.
Epub 2022 Dec 9.
Author
Sara M Mangsbo
1
Affiliation
1
Department of Pharmacy, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
PMID:
36484462
DOI:
10.1080/14712598.2022.2156784
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
Cancer Vaccines*
Humans
Peptides* / therapeutic use
Vaccination
Substances
Peptides
Cancer Vaccines